Although it varies from center to center, the frequency of temporal artery biopsy in patients suspected of having temporal arteritis (TA) is relatively small. Most commonly, patients suspected of having TA are placed on prednisone for varying periods of time, and if symptoms disappear or lessen the diagnosis is made. During a recent 13-year period at Baylor University Medical Center at Dallas, 15 patients with TA had the diagnosis of TA confirmed by histological examination of a biopsy of one temporal artery. The length of the biopsied artery varied from 0.7 to 5.5 cm (mean 2.7). The 15 patients ranged in age from 68 to 94 years (mean 82, median 85), and 11 (73%) were women. In 13 of the 15 patients (87%), the lumen of the temporal artery was narrowed >95% in cross-sectional area by the panarteritis, and the temporal artery was associated with giant cells in 11 patients (73%). Large collections of erythrocytes were present in the inflamed arterial walls in 5 patients (33%). All 15 patients were treated with varying doses of prednisone with favorable response in each. Eight patients (53%) died from 1 to 105 months (mean 52, median 57) after biopsy of the temporal artery. We have neither positive nor negative evidence that the TA played a role in the patients' death. Despite the present study and numerous others in the last 70 years, the cause of TA remains a mystery. I n 1932 and in 1934, Bayard T. Horton, a vascular specialist at the Mayo Clinic, and others (1, 2) reported two patients with headache, scalp tenderness, weight loss, fever, and night sweats, and histologic examination of one biopsied temporal artery disclosed granulomatous panarteritis. Th ereafter, the condition was called temporal arteritis (TA) by some and Horton's disease by others. In 1937, Horton and Magath (3) described visual loss, jaw claudication, and elevated erythrocyte sedimentation rates in several additional patients with the disease. According to Boes (4), Horton in 1942 was the fi rst to give a patient with TA Kendall's adrenocorticoid extract (nonpure), but apparently it had no eff ect on the patient's disease. Shick and colleagues (5), in 1950, also at the Mayo Clinic, reported clinical improvement in two patients with TA using a pure form of cortisone. Th e present study summarizes fi ndings in 15 patients with TA seen at Baylor University Medical Center at Dallas (BUMC) in the last 13 years and describes in detail the various histological features in the temporal artery in these patients. 
METHODS
Cases coded as TA by the surgical pathology division of the Department of Pathology of BUMC from 1997 through 2012 were retrieved. Fifteen such cases having biopsy of one temporal artery were found. Th e paraffi n blocks of the temporal artery in each patient were retrieved and recut. Th e resulting 6-micron-thick sections were stained by both the hematoxylineosin method and by the Movat method, and the sections were examined. Th e clinical records in each patient were retrieved and examined in the BUMC record room, and pertinent fi ndings were tabulated in each patient. Finally, the Social Security Death Index was searched to determine how many of the 15 patients had died. Tables 1 and 2 . Th e 15 patients ranged in age from 68 to 94 years (mean 82) at the time of the temporal artery biopsy; 11 were women and 4 were men. Th e age at biopsy in all 15 patients corresponded to the age at which symptoms and/or signs of TA appeared. Th e symptoms at the time of temporal artery biopsy are displayed for each patient in Table 1 : headache in 12, visual disturbance in 10, mastication pain in 7, and temporal artery tenderness in 6. At the time of biopsy, the indirect systemic arterial pressure was ≥140 mm Hg systolic and/or ≥90 mm Hg diastolic in 11 patients (73%). Th e body mass index was >25 kg/m 2 in 8 of the 15 patients, but in none was it ≥30 kg/m 2 . Anemia (hematocrit <35%) was present in 8 (57%) of the 14 patients in which the result of this test was available. Th e platelet count was >250 mm 3 in 9 of the 11 patients in whom it was performed. Th e erythrocyte sedimentation rates were elevated (>20 mm/hour) in all 10 patients where the results were available. Th e serum C-reactive protein was elevated in all 5 patients in which it was done. One patient (#2) had an aortic aneurysm, and one patient (#8) had had a stroke a few months before biopsy. Th e length of the temporal artery biopsied ranged from 0.7 to 5.5 cm (mean 2.7); sample images and descriptions appear in Figures 1 to 9 . In 13 of the 15 patients (87%), the lumen of the temporal artery was narrowed >95% in cross-sectional area. Th e temporal artery was associated with giant cells in 11 patients (73%). All 15 patients received prednisone (maximal dose 40-70 mg) for 0.25 to 73 months (mean 22) , and all had symptomatic improvement, including 5 with loss or virtual loss of symptoms.
RESULTS

Pertinent fi ndings in the 15 patients are summarized in
DISCUSSION
It might seem a bit inappropriate in 2013 to report a series of only 15 patients with biopsy-proven TA when others have reported such large series of patients with biopsy-proven TA . Gonzalez-Gay and colleagues (13, 19, 20, 25, 26, 28, 31) , for example, in 7 articles from 1998 to 2011 described anywhere from 161 to 255 patients with biopsy-proven TA (called "giant cell arteritis" by the authors), but none contained a photomicrograph of a temporal artery. Indeed, of the 30 studies presented in Table 3 , only two included a photomicrograph of a temporal artery, and in both only hematoxylineosin-stained sections had been used. It is not possible to demonstrate the locations of the panarteritis, i.e., how much of the process involved the intima, media, and adventitia, without an elastic tissue stain that readily identifi es the internal and external elastic membranes allowing clear demonstration of media, thus separating it from the intima and adventitia. We employed the Movat stain for this purpose in our study (36) .
We prefer the phrase "temporal arteritis" to the phrase "giant cell arteritis" because giant cells are not seen in all TA patients having biopsies of the temporal arteries. Among our 15 patients, we found giant cells in only 11. Mahr and colleagues (37) suggested that fi nding giant cells in patients with TA is determined in part by the lengths of the temporal arteries examined. Th ese authors examined surgical BMI indicates body mass index; BP, blood pressure; CRP, C-reactive protein; CS, cigarette smokers; ESR, erythrocyte sedimentation rate; H, headache; HCT, hematocrit; Hgb, hemoglobin; LC, leg claudication; MP, mastication pain; PR, polymyalgia rheumatica; S/D, peak systole/end diastole; VD, visual disturbance; -, not done, not applicable, or no information.
Symptoms at time of biopsy reports of temporal artery biopsies in 223 patients with TA and found that 164 (74%) of the reports mentioned the presence of giant cells. Th ese authors also mentioned that a temporal artery length of at least 0.5 cm was suffi cient for diagnosis of TA. Our smallest length among the patients was 0.7 cm. Among the four patients in whom we did not see giant cells, the lengths of the temporal artery biopsied were 0.7, 2.6, 3.0, and 3.5 cm; the latter three lengths were among the longest in the patients we studied. Although the present study focuses on the histologic features of TA, one might reasonably ask if biopsy of this artery is a useful routine endeavor. A near universal observation in TA is a rapid, sometimes dramatic, diminution or loss of symptoms after corticosteroid therapy has been initiated. If there is not a quick symptomatic response, biopsy can then be performed. Th ere appears to be little change in the histologic features of the TA before corticosteroid therapy and up to about 6 weeks after initiation of therapy (10) . A report by Guevara et al described a positive biopsy after 6 months of prednisone treatment (38) . If a patient with suspected TA has a negative biopsy of the temporal artery, is it useful then to biopsy the contralateral temporal artery? According to a study by Boyev and colleagues (18) , biopsy of one temporal artery in a patient with TA provides a 97% chance that the same fi ndings would be present in the contralateral temporal artery, so that the additional biopsy would rarely be useful diagnostically.
On occasion, TA resolves without corticosteroid therapy. Horton et al, in their original two patients, described temporary remissions with relapses (1), and they later described seven additional patients in whom remission occurred without drug therapy months after diagnosis (3). Patients have been described where headaches and local symptoms have disappeared simply by removal of a portion of the temporal artery for diagnostic purposes (39, 40) . 
